Interferon β-1b retinopathy during a treatment for multiple sclerosis

被引：0
|
作者：
Sommer, S [1 ]
Sablon, JC [1 ]
Zaoui, M [1 ]
Rozot, P [1 ]
Hosni, A [1 ]
机构：
[1] CHR ND Bonsecours, F-57038 Metz 1, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2001年 / 24卷 / 05期
关键词：
interferon; multiple sclerosis; cotton wool spots; retinopathy;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Ocular adverse effects of interferon are described during the treatment of malignant diseases and chronic viral hepatitis with interferon alpha. At this time, there is no report of these effects during multiple sclerosis treatment with interferon beta -1b. The authors report a bilateral retinopathy during this treatment. The production of neutralizing antibodies during interferon beta -1b treatment leads to a decreese in diminution of therapeutic efficacy. When treatment failure occurs, neutralizing antibodies are to be tested.
引用
收藏
页码：509 / 512
页数：4
相关论文
共 50 条
  • [1] Treatment of multiple sclerosis with interferon β1b
    Dhib-Jalbut, S
    McFarland, HF
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 467 - 480
  • [2] Interferon-β1b for the treatment of multiple sclerosis
    Lam, Sum
    Wang, Shan
    Gottesman, Malcolm
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (08) : 1111 - 1117
  • [3] Interferon-β1b in the treatment of multiple sclerosis
    Río, J
    Montalban, X
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2877 - 2886
  • [4] Multiple Sclerosis and Cognition under Treatment with Interferon β-1b
    Toennes, C.
    Linker, R. A.
    AKTUELLE NEUROLOGIE, 2009, 36 : S257 - S259
  • [5] Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain
    Fernandez, Oscar
    Agueera, Javier
    Izquierdo, Guillermo
    Millan-Pascual, Javier
    Ramio i Torrenta, Lluis
    Oliva, Pedro
    Argente, Javier
    Berdei, Yasmina
    Maria Soler, Jose
    Carmona, Olga
    Maria Errea, Jose
    Farres, Jordi
    PLOS ONE, 2012, 7 (05):
  • [6] Intestinal microbiota in multiple sclerosis: influence of treatment with interferon β-1b
    Castillo Alvarez, F.
    Perez Matute, P.
    Colina Lizuain, S.
    Erdocia Goni, A.
    Gutierrez Cecchini, C. Iglesias
    Gomez Eguilaz, M.
    Lopez Perez, M. A.
    Marzo Sola, E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 190 - 190
  • [7] Cutaneous Vasculitis Associated With Interferon β-1b Treatment for Multiple Sclerosis
    Szilasiova, Jarmila
    Gdovinova, Zuzana
    Jautova, Jagienka
    Baloghova, Janette
    Ficova, Marta
    Bohus, Peter
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (05) : 301 - 303
  • [8] Treatment of patients with secondary progressive multiple sclerosis with interferon β-1b
    Robert P. Lisak
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 246 - 248
  • [9] No evidence for increased frequency of autoantibodies during interferon-β1b treatment of multiple sclerosis
    Kivisakk, P
    Lundahl, J
    von Heigl, Z
    Fredrikson, S
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (05): : 320 - 323
  • [10] Azathioprine and interferon β-1b treatment in relapsing-remitting multiple sclerosis
    Milanese, C
    La Mantia, L
    Salmaggi, A
    Caputo, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03): : 413 - 414
12345